(Q33868638)

29 July 2017

1 reference

title

Opioid dependence treatment: options in pharmacotherapy (English)

1 reference

29 July 2017

0 references

0 references

Angela L Stotts

1

1 reference

29 July 2017

Carrie L Dodrill

series ordinal

2

1 reference

29 July 2017

Thomas R Kosten

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Expert Opinion on Pharmacotherapy

29 July 2017

1 reference

29 July 2017

10

1 reference

29 July 2017

11

1 reference

29 July 2017

1727-1740

1 reference

Buprenorphine for the management of opioid withdrawal

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine tapering schedule and illicit opioid use.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine treatment in an urban community health center: what to expect

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Post-treatment outcomes of buprenorphine detoxification in community settings: a systematic review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

The future of vaccines in the management of addictive disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Management of relapse in naltrexone maintenance for heroin dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine for the management of opioid withdrawal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

The place of detoxification in treatment of opioid dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Oral naltrexone maintenance treatment for opioid dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Medication development for addictive disorders: the state of the science

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Vaccine pharmacotherapy for the treatment of cocaine dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Methadone at tapered doses for the management of opioid withdrawal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Alpha2 adrenergic agonists for the management of opioid withdrawal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

The Effectiveness of Combined Naloxone/Lofexidine in Opiate Detoxification: Results from a Double-blind Randomized and Placebo-controlled Trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine: how to use it right

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995-99.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

History and current status of opioid maintenance treatments: blending conference session

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Naltrexone and dysphoria: fact or myth?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Treatment of heroin dependence with buprenorphine in primary care

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Injecting misuse of buprenorphine among French drug users

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Opioid antagonists and adrenergic agonists for the management of opioid withdrawal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Optimizing response to methadone maintenance treatment: use of higher-dose methadone

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine and naloxone interactions in methadone maintenance patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine versus methadone maintenance for opioid dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clinical pharmacology of buprenorphine: ceiling effects at high doses

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Naltrexone: A Short-Term Treatment for Opiate Dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

The neurobiological implication of clonidine HCl.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clinical experience with naltrexone in suburban opioid addicts.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Methadone Treatment of Randomly Selected Criminal Addicts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clinical evaluation of a naltrexone sustained-release preparation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clinical Utility of Rapid Clonidine-naltrcxone Detoxification for Opioid Abusers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clonidine and the treatment of the opiate withdrawal syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Naltrexone-induced dysphoria in former opioid addicts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Mortality in heroin addiction: impact of methadone treatment.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Clonidine blocks acute opiate-withdrawal symptoms

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Withdrawal from methadone maintenance treatment: prognosis and participant perspectives

28 July 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Comparison of buprenorphine and methadone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A meta-analysis comparing the effectiveness of buprenorphine and methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Data do not support buprenorphine as a first-line treatment for addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Pharmacological advances in addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine or methadone for detoxification of young opioid addicts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Buprenorphine dosing regime in the management of out-patient heroin withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Three methods of opioid detoxification in a primary care setting. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Comparison of methadone and high dosage buprenorphine users in French care centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Recent evolution in opiate dependence in France during generalisation of maintenance treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Differences between general practitioner- and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Addiction pharmacotherapy 2000: new options, new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Survey of hepatitis B and C in addiction treatment unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Primary care-based ambulatory opioid detoxification: the results of a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Lofexidine versus clonidine in rapid opiate detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Naltrexone shortened opioid detoxification with buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Naltrexone and buprenorphine combination in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A death following ultra-rapid opiate detoxification: the General Medical Council adjudicates on a commercialized detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Unplanned admissions to two Sydney public hospitals after naltrexone implants.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

Opioid overdose deaths can occur in patients with naltrexone implants.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2874458

High-Dose Naltrexone and Liver Function Safety

29 October 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Naltrexone-Assisted Rapid Methadone Discontinuation: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

A Preliminary Investigation of the Management of Alcohol Dependence With Naltrexone by Primary Care Providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903037168

Sustained-release naltrexone for alcoholism treatment: a preliminary study

21 January 2018

1 reference

12 December 2020

Acute administration of buprenorphine in humans: partial agonist and blockade effects

1 reference

12 December 2020

Withdrawal from methadone maintenance. Rate of withdrawal and expectation

1 reference

12 December 2020

Clonidine and opiate receptor antagonists in the treatment of heroin addiction

1 reference

12 December 2020

Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet

1 reference

12 December 2020

Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors

1 reference

12 December 2020

Lofexidine in opiate withdrawal: a safety and usage survey

1 reference

12 December 2020

Behavioral naltrexone therapy: an integrated treatment for opiate dependence

1 reference

12 December 2020

A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification

1 reference

12 December 2020

Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment

1 reference

12 December 2020

Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial

1 reference

12 December 2020

Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification

1 reference

12 December 2020

Clonidine for opiate detoxification: outpatient clinical trials

1 reference

12 December 2020

Buprenorphine in opiate withdrawal: a comparison with clonidine

1 reference

12 December 2020

Blood naltrexone levels over time following naltrexone implant

1 reference

12 December 2020

Study of hepatotoxicity of naltrexone in the treatment of alcoholism

1 reference

12 December 2020

Clonidine in outpatient detoxification from methadone maintenance

1 reference

12 December 2020

A Comparison of Clonidine and Buprenorphine in the Outpatient Treatment of Opiate Withdrawal

1 reference

12 December 2020

10.1517/14656560903037168

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference